News

Tirzepatide conferred significantly greater weight loss than semaglutide at 72 weeks for adults with overweight or obesity, ...
Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.
The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published ...
While the primary target for these medication is weight loss, it’s not the only metric by which the drugs should be evaluated ...
In the first head-to-head comparison of leading incretin-based therapies, Eli Lilly’s dual GIP/GLP-1 receptor agonist ...
Weight-loss jab Mounjaro helps people shed much more weight than rival – study - Mounjaro (tirzepatide) and Wegovy ...
Weight loss injections may have a powerful anti-cancer effect, new research suggests. Experts already know that losing weight ...